<DOC>
	<DOCNO>NCT00731705</DOCNO>
	<brief_summary>The doctor Bone Marrow Transplant Service Indiana University Cancer Center work well understand immune cell cause graft-versus-host disease ( major complication stem cell transplantation donor immune cell attack patient 's organ ) selectively remove graft , leave immune cell fight infection .</brief_summary>
	<brief_title>In-Vitro Studies Depletion Haplotype Mismatched Alloreactive T Cells</brief_title>
	<detailed_description>The purpose research study immune cell ( call T cell ) cause graft-versus-host disease ( GVHD ) best selectively separate T cell remove cell return cancer patient 's body . These T cell may protect infection give patient stem cell transplant . The removal cell cause GVHD would allow doctor safely give back T cell protect infection , without risk GVHD .</detailed_description>
	<criteria>Patients hematological malignancy undergo evaluation autologous allogeneic stem cell transplant eligible , : ( 1 ) They circulate neoplastic cell peripheral blood assess routine morphology flow cytometry . ( 2 ) Patients acute myeloid lymphocytic leukemia complete remission Firstdegree relatives patient evaluated stem cell transplantation eligible : ( 1 ) Willing undergo test HIV hepatitis B C ( free charge ) ( 2 ) Not pregnant time collection blood ( 3 ) In good general health ( 4 ) No prior history malignancy . ( 5 ) Age 18 year old donate apheresis product . ( Because relatively invasive nature leukopheresis procedure difficulty obtain consent , child &lt; 18 first degree relatives patient undergo apheresis study protocol ) Written inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>